logo
Share SHARE
FONT-SIZE Plus   Neg

Quest Diagnostics To Sell HemoCue Diagnostic Products Business For $300 Mln

Quest Diagnostics (DGX: Quote), a provider of diagnostic information services, Monday said it has signed a definitive agreement to sell its HemoCue diagnostic products business to Radiometer Medical ApS for around $300 million plus customary adjustments for cash balances.

HemoCue develops, produces and markets hemoglobin, glucose and other point-of-care testing systems worldwide.

Steve Rusckowski, President and CEO of Quest Diagnostics, said, "The HemoCue divestiture, along with our sale of OralDNA in December 2012, demonstrates our commitment to refocus our business on diagnostic information services."

Quest plans to use the proceeds to repurchase around $300 million of its shares as part of its stock buyback program.

The transaction is expected to be completed in March.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Trolling celebrities on Twitter has been a favorite pastime for many. But now, Twitter has announced new updates to deal with such trolls, just weeks after CEO Dick Costolo admitted that the micro-blogging site "sucks" when it comes to dealing with trolls. Twitter said it has improved the process... You will soon be able to eat your coffee cups rather that looking for bins to dispose them. Fast-Food chain KFC will be launching the unique edible coffee cups that you can munch after you have slurped your hot cup of beverage. The heat-resistant chocolate coated cookie biscuit cup called "Scoff-ee... Fiat Chrysler Automobiles NV (FCAU) is recalling nearly 26 thousand Chrysler 200s to fix a transmission issue that may prevent the vehicle from shifting into "park." Chrysler said that certain 2015-model year Chrysler 200 vehicles with V6 engines were affected. Chrysler blamed "inconsistent assembly...
comments powered by Disqus
Follow RTT